Fresenius Medical Care AG & Co. KGaA (ETR: FME – Get a rating) was assigned a price target of €58.00 ($59.18) by equity research analysts Deutsche Bank Rese… in a report on Friday, Borsen Zeitung reports. Deutsche Bank Rese…’s target price would indicate upside potential of 60.40% from the company’s previous close.
Other equity research analysts have also recently published research reports on the stock. UBS Group set a price target of €38.00 ($38.78) on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Friday. Berenberg Bank set a price target of €76.70 ($78.27) on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday. Deutsche Bank Aktiengesellschaft set a price target of €58.00 ($59.18) on shares of Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research report. Credit Suisse Group set a price target of €61.00 ($62.24) on shares of Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 report. Finally, JPMorgan Chase & Co. set a price target of €23.00 ($23.47) on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Friday.
Pricing performance of Fresenius Medical Care AG & Co. KGaA
ETR: FME open at €36.16 ($36.90) on Friday. The company has a 50-day moving average of €49.26 and a 200-day moving average of €55.75. The company has a market capitalization of $10.60 billion and a price-earnings ratio of 12.05. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €37.37 ($38.13) and a 52-week high of €69.96 ($71.39). The company has a debt ratio of 91.78, a quick ratio of 0.79 and a current ratio of 1.26.
Fresenius Medical Care AG & Co. KGaA Company Profile
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.
Featured articles
Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .
